TY - JOUR
T1 - HF-DDI
T2 - Predicting Drug-Drug Interaction Events Based on Multimodal Hybrid Fusion
AU - Huang, An
AU - Xie, Xiaolan
AU - Yao, Xiaojun
AU - Liu, Huanxiang
AU - Wang, Xiaoqi
AU - Peng, Shaoliang
N1 - Funding Information:
This study was supported by NSFC Grants (62262011, U19A2067); Natural Science Foundation of Guangxi (2021JJA170130); National Key R&D Program of China (2022YFC3400404); The Funds of State Key Laboratory of Chemo/Biosensing and Chemometrics, the National Supercomputing Center in Changsha ( http://nscc.hnu.edu.cn/ ), and Peng Cheng Lab.
Publisher Copyright:
Copyright 2023, Mary Ann Liebert, Inc., publishers.
PY - 2023/9/1
Y1 - 2023/9/1
N2 - Drug-drug interactions (DDIs) can have a significant impact on patient safety and health. Predicting potential DDIs before administering drugs to patients is a critical step in drug development and can help prevent adverse drug events. In this study, we propose a novel method called HF-DDI for predicting DDI events based on various drug features, including molecular structure, target, and enzyme information. Specifically, we design our model with both early fusion and late fusion strategies and utilize a score calculation module to predict the likelihood of interactions between drugs. Our model was trained and tested on a large data set of known DDIs, achieving an overall accuracy of 0.948. The results suggest that incorporating multiple drug features can improve the accuracy of DDI event prediction and may be useful for improving drug safety and patient outcomes.
AB - Drug-drug interactions (DDIs) can have a significant impact on patient safety and health. Predicting potential DDIs before administering drugs to patients is a critical step in drug development and can help prevent adverse drug events. In this study, we propose a novel method called HF-DDI for predicting DDI events based on various drug features, including molecular structure, target, and enzyme information. Specifically, we design our model with both early fusion and late fusion strategies and utilize a score calculation module to predict the likelihood of interactions between drugs. Our model was trained and tested on a large data set of known DDIs, achieving an overall accuracy of 0.948. The results suggest that incorporating multiple drug features can improve the accuracy of DDI event prediction and may be useful for improving drug safety and patient outcomes.
KW - drug-drug interaction
KW - feature fusion
KW - multimodal deep learning
UR - http://www.scopus.com/inward/record.url?scp=85170426148&partnerID=8YFLogxK
U2 - 10.1089/cmb.2023.0068
DO - 10.1089/cmb.2023.0068
M3 - Article
AN - SCOPUS:85170426148
SN - 1066-5277
VL - 30
SP - 961
EP - 971
JO - Journal of Computational Biology
JF - Journal of Computational Biology
IS - 9
ER -